Totally implantable central venous access device in the treatment of patients with multi- and extensively drug-resistant tuberculosis co-infected with human immunodeficiency virus and with history of illicit drug use.

Source: International Congress 2018 – Tuberculosis comorbidities

Session: Tuberculosis comorbidities
Session type: Thematic Poster
Number: 2707

Disease area: Respiratory infections



Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Skrahin (Minsk, Belarus), M. Makouski (Minsk, Belarus), D. Pechinsky (Minsk, Belarus), K. Dobysh (Minsk, Belarus), H. Hlushanina (Minsk, Belarus), A. Sinha (Minsk, Belarus), A. Skrahina (Minsk, Belarus). Totally implantable central venous access device in the treatment of patients with multi- and extensively drug-resistant tuberculosis co-infected with human immunodeficiency virus and with history of illicit drug use.. 2707

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

• IGRAs and other TB infection tests
• The updated treatment algorithm in PAH
• Diagnosis and treatment of chronic pulmonary embolism